Dr. Ray Takigiku

CEO and founder of Bexion
Biochemistry
Bexion
United States of America

Biography

Dr. Ray Takigiku, CEO and founder of Bexion Pharmaceuticals, received Food and Drug Administration approval last year to begin phase-one clinical trials on his company’s anti-cancer drug BQX-350. Based in Covington KY, Bexion is a privately held biotech company focused on the development and commercialization of innovative cures for cancer. (Photo: Kentucky Cabinet for Economic Development)

Research Interest

intrested in biochemical production

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America